Analyses / MDB
High-growth SaaS facing profitability headwinds; rally stalling near resistance.
A free account reveals MDB's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.
The Thesis
▲ Bull Case
YoY revenue growth 24.3% with 33% 5-year CAGR signals strong market adoption. Gross margin 71.8% underpins pricing power & unit economics. Current ratio 4.65 shows fortress balance sheet. In a bull scenario, margin expansion + acceleration into 2026 could justify premium multiples if execution steadies.
▼ Bear Case
Negative operating margin (-5.6%) and net margin (-2.9%) mean the company is not yet profitable at scale. P/S 10.7x is elevated for unprofitable software. Price rallied 63% off 52-week low ($198)—momentum may be exhausted. Insider selling vastly exceeds buying (540k vs 245k shares), a red flag. Forward earnings growth unclear with no forward P/E available.
Valuation
overvalued — score 38/100
P/S 10.7x is 2–3x industry median for SaaS given negative operating margins. No profitability yet. Justified only if growth accelerates AND margins inflect sharply. Current setup prices in success; limited upside if execution stumbles.
Technical Levels
Support · $310.00 (Recent intraday low; near 20-day MA) · $295.00 (Key support; -9% from current) · $270.00 (2024 breakout level; major support)
Resistance · $330.00 (Daily high; prior rally peak) · $350.00 (Psychological level; -21% below 52-week high) · $370.00 (Test of 2024 highs)
RSI: Not available
Financial Health
Score 78/100. Balance sheet fortress (current/quick ratios >4.5) provides runway for losses. No immediate solvency risk. However, cash burn and lack of profitability are concerning long-term. Company is reinvesting heavily in growth but has not yet monetized success.
Catalysts
| Q4 2025 / FY2025 earnings (likely Feb 2026 report) | ~8–10 weeks | high |
| Margin inflection narrative (path to profitability) | Next earnings or guidance | high |
| Product adoption / land-and-expand metrics (ARR, net dollar retention) | Quarterly updates | medium |
| Insider buying resumption (reversal of current selling trend) | Next 6 months | medium |
| Macro / rate environment shift (lower rates = re-rating of growth) | Ongoing | high |
Risk Flags
See MDB's full trade plan — free
Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.
Unlock MDB free →Recent News
- Artisan Mid Cap Fund Q2 2026 Performance ReviewSeekingAlpha
You've read your 2 free analyses
Create a free account for unlimited analyses — every name on the page, plus live tools on 5,000+ tickers. No card required.
Read the full MDB analysis — free →Free to read · 2 analyses every 30 days without an account
More Analyses
MDB FAQ
Is MDB a buy right now?
MongoDB Inc's current read is a Growth-at-premium with deteriorating fundamentals setup with 65 confidence over a 3-6 months horizon. Valuation: overvalued. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.
Is MDB overvalued?
overvalued (valuation score 38/100). P/S 10.7x is 2–3x industry median for SaaS given negative operating margins. No profitability yet. Justified only if growth accelerates AND margins inflect sharply. Current setup prices in success; limited upside if execution stumbles.
What are the risks of buying MDB?
Negative operating margin (-5.6%) and net margin (-2.9%) mean the company is not yet profitable at scale. P/S 10.7x is elevated for unprofitable software. Price rallied 63% off 52-week low ($198)—momentum may be exhausted. Insider selling vastly exceeds buying (540k vs 245k shares), a red flag. Forward earnings growth unclear with no forward P/E available.